Canada markets closed

InMed Pharmaceuticals Inc. (INM)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.2520-0.0510 (-16.83%)
At close: 04:00PM EDT
0.2600 +0.01 (+3.17%)
After hours: 07:26PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
2020-06-30
Total Revenue
5,487
4,136
1,089
0
0
Cost of Revenue
3,379
2,733
545.889
0
-
Gross Profit
2,108
1,403
543.546
0
-
Operating Expenses
Research Development
3,404
3,732
7,283
5,338
5,811
Selling General and Administrative
5,485
5,848
6,867
4,479
3,227
Total Operating Expenses
9,103
9,782
14,335
9,938
9,151
Operating Income or Loss
-6,995
-8,379
-13,792
-9,938
-9,151
Interest Expense
-
-
0
360.35
0
Total Other Income/Expenses Net
39.818
-48.175
-4,904
79.527
82.187
Income Before Tax
-6,348
-7,935
-18,600
-10,203
-8,939
Income Tax Expense
3.3
13.1
0
-
-
Income from Continuing Operations
-6,351
-7,948
-18,600
-10,203
-8,939
Net Income
-6,351
-7,948
-18,600
-10,203
-8,939
Net Income available to common shareholders
-6,351
-7,948
-18,600
-10,203
-8,939
Basic EPS
0.05
-3.25
-1.33
-37.96
-42.75
Diluted EPS
0.05
-3.25
-1.33
-37.96
-42.75
Basic Average Shares
3,064
2,448
14,021
268.793
208.828
Diluted Average Shares
3,064
2,448
14,021
268.793
208.828